Terms: = Breast cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Prognosis
23 results:
1. sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
2. The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer.
Choi JE; Lee JS; Jin MS; Nikas IP; Kim K; Yang S; Park SY; Koh J; Yang S; Im SA; Ryu HS
Breast Cancer Res; 2023 Nov; 25(1):134. PubMed ID: 37924153
[TBL] [Abstract] [Full Text] [Related]
3. PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma.
Matsubara E; Shinchi Y; Komohara Y; Yano H; Pan C; Fujiwara Y; Ikeda K; Suzuki M
Med Mol Morphol; 2023 Dec; 56(4):250-256. PubMed ID: 37402054
[TBL] [Abstract] [Full Text] [Related]
4. nc-RNA-mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer.
Zhao YX; Xu BW; Wang FQ; Jiang FY; Xu JW; Yu DX
Cancer Med; 2023 Feb; 12(4):5110-5123. PubMed ID: 36457244
[TBL] [Abstract] [Full Text] [Related]
5. Immune Evasion of Hepatoma cancer Stem-Like Cells from Natural Killer Cells.
Kimura Y; Tsunedomi R; Yoshimura K; Matsukuma S; Shindo Y; Matsui H; Tokumitsu Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
Ann Surg Oncol; 2022 Nov; 29(12):7423-7433. PubMed ID: 35876924
[TBL] [Abstract] [Full Text] [Related]
6. Implications of PD-1, Tim-3, and TIGIT Expression for cancer Immunity and Pancreatic cancer prognosis.
Nakayama C; Tanoue K; Idichi T; Shimomura H; Kita Y; Hozaka Y; Shinden Y; Matsushita D; Nakajo A; Arigami T; Mataki Y; Kurahara H; Ohtsuka T
Anticancer Res; 2022 Jul; 42(7):3373-3380. PubMed ID: 35790289
[TBL] [Abstract] [Full Text] [Related]
7. DNA-Functionalized Liposomes
Zhang N; Shu G; Qiao E; Xu X; Shen L; Lu C; Chen W; Fang S; Yang Y; Song J; Zhao Z; Tu J; Xu M; Chen M; Du Y; Ji J
ACS Appl Mater Interfaces; 2022 May; 14(18):20603-20615. PubMed ID: 35476429
[TBL] [Abstract] [Full Text] [Related]
8. Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer progression.
Qi M; Xia Y; Wu Y; Zhang Z; Wang X; Lu L; Dai C; Song Y; Xu K; Ji W; Zhan L
Nat Commun; 2022 Feb; 13(1):897. PubMed ID: 35173168
[TBL] [Abstract] [Full Text] [Related]
9. Developing an immune signature for triple-negative breast cancer to predict prognosis and immune checkpoint inhibitor response.
Wang C; Feng G; Zhu J; Wei K; Huang C; Wu Z; Yu Y; Qin G
Future Oncol; 2022 Mar; 18(9):1055-1066. PubMed ID: 35105171
[No Abstract] [Full Text] [Related]
10. Nicotine treatment regulates PD-L1 and PD-L2 expression via inhibition of Akt pathway in HER2-type breast cancer cells.
Murayama MA; Takada E; Takai K; Arimitsu N; Shimizu J; Suzuki T; Suzuki N
PLoS One; 2022; 17(1):e0260838. PubMed ID: 35085258
[TBL] [Abstract] [Full Text] [Related]
11. Effect of Primary Systemic Therapy on PD-1, PD-L1, and PD-L2 mRNA Expression in Advanced breast cancer.
Karsono R; Azhar MA; Pratiwi Y; Saputra F; Nadliroh S; Aryandono T
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2069-2077. PubMed ID: 34319029
[TBL] [Abstract] [Full Text] [Related]
12. Omission of Chemotherapy in HR+/HER2- Early Invasive breast cancer Based on Combined 6-IHC Score?
Lin J; Guo Z; Wang S; Zheng X
Clin Breast Cancer; 2021 Oct; 21(5):e565-e574. PubMed ID: 33674187
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis.
Zhang S; Ma F; Xie X; Shen Y
Medicine (Baltimore); 2020 Sep; 99(37):e21861. PubMed ID: 32925722
[TBL] [Abstract] [Full Text] [Related]
14. Deep learning-based survival analysis for brain metastasis patients with the national cancer database.
Bice N; Kirby N; Bahr T; Rasmussen K; Saenz D; Wagner T; Papanikolaou N; Fakhreddine M
J Appl Clin Med Phys; 2020 Sep; 21(9):187-192. PubMed ID: 32790207
[TBL] [Abstract] [Full Text] [Related]
15. Expression pattern of m
He X; Tan L; Ni J; Shen G
Cancer Gene Ther; 2021 Apr; 28(3-4):188-196. PubMed ID: 32759989
[TBL] [Abstract] [Full Text] [Related]
16. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic significance of PD-L1 and PD-L2 in breast cancer.
Baptista MZ; Sarian LO; Derchain SF; Pinto GA; Vassallo J
Hum Pathol; 2016 Jan; 47(1):78-84. PubMed ID: 26541326
[TBL] [Abstract] [Full Text] [Related]
18. Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer.
Barrett MT; Anderson KS; Lenkiewicz E; Andreozzi M; Cunliffe HE; Klassen CL; Dueck AC; McCullough AE; Reddy SK; Ramanathan RK; Northfelt DW; Pockaj BA
Oncotarget; 2015 Sep; 6(28):26483-93. PubMed ID: 26317899
[TBL] [Abstract] [Full Text] [Related]
19. High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer.
Tymoszuk P; Charoentong P; Hackl H; Spilka R; Müller-Holzner E; Trajanoski Z; Obrist P; Revillion F; Peyrat JP; Fiegl H; Doppler W
BMC Cancer; 2014 Apr; 14():257. PubMed ID: 24725474
[TBL] [Abstract] [Full Text] [Related]
20. A hybrid approach to survival model building using integration of clinical and molecular information in censored data.
Choi I; Kattan MW; Wells BJ; Yu C
IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(4):1091-1105. PubMed ID: 22350208
[TBL] [Abstract] [Full Text] [Related]
[Next]
